Filing Details
- Accession Number:
- 0000899243-22-005005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-07 16:05:16
- Reporting Period:
- 2022-01-20
- Accepted Time:
- 2022-02-07 16:05:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1659352 | Codiak Biosciences Inc. | CDAK | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1828135 | Nicole Barna | C/O Codiak Biosciences, Inc. 35 Cambridgepark Drive, Suite 500 Cambridge MA 02140 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-01-20 | 6,781 | $7.37 | 6,781 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- On January 20, 2022, the reporting person purchased 6,781.257 shares of the Issuer's common stock at a price of $7.37 per share.